Kiss H, Yang Y, Kiss C, et al.: The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3. In: Eur. J. Hum. Genet. 10. Jahrgang, Nr.1, Januar 2002, S.52–61, doi:10.1038/sj.ejhg.5200758, PMID 11896456.
Chandrasekar B, Bysani S, Mummidi S: CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. In: J. Biol. Chem. 279. Jahrgang, Nr.5, Januar 2004, S.3188–96, doi:10.1074/jbc.M311660200, PMID 14625285.
Zernecke A, Shagdarsuren E, Weber C: Chemokines in atherosclerosis: an update. In: Arterioscler. Thromb. Vasc. Biol. 28. Jahrgang, Nr.11, November 2008, S.1897–908, doi:10.1161/ATVBAHA.107.161174, PMID 18566299.
Aslanian AM, Charo IF: Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. In: Circulation. 114. Jahrgang, Nr.6, August 2006, S.583–90, doi:10.1161/CIRCULATIONAHA.105.540583, PMID 16880330.
Alkhatib G, Liao F, Berger EA, Farber JM, Peden KW: A new SIV co-receptor, STRL33. In: Nature. 388. Jahrgang, Nr.6639, Juli 1997, S.238, doi:10.1038/40789, PMID 9230431.
nih.gov
ncbi.nlm.nih.gov
Murphy PM: International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. In: Pharmacol Rev. 54. Jahrgang, Nr.2, 2002, S.227–229, PMID 12037138.
Kiss H, Yang Y, Kiss C, et al.: The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3. In: Eur. J. Hum. Genet. 10. Jahrgang, Nr.1, Januar 2002, S.52–61, doi:10.1038/sj.ejhg.5200758, PMID 11896456.
Chandrasekar B, Bysani S, Mummidi S: CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. In: J. Biol. Chem. 279. Jahrgang, Nr.5, Januar 2004, S.3188–96, doi:10.1074/jbc.M311660200, PMID 14625285.
Zernecke A, Shagdarsuren E, Weber C: Chemokines in atherosclerosis: an update. In: Arterioscler. Thromb. Vasc. Biol. 28. Jahrgang, Nr.11, November 2008, S.1897–908, doi:10.1161/ATVBAHA.107.161174, PMID 18566299.
Aslanian AM, Charo IF: Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. In: Circulation. 114. Jahrgang, Nr.6, August 2006, S.583–90, doi:10.1161/CIRCULATIONAHA.105.540583, PMID 16880330.
Alkhatib G, Liao F, Berger EA, Farber JM, Peden KW: A new SIV co-receptor, STRL33. In: Nature. 388. Jahrgang, Nr.6639, Juli 1997, S.238, doi:10.1038/40789, PMID 9230431.
Liao F, Alkhatib G, Peden KW, Sharma G, Berger EA, Farber JM: STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. In: J. Exp. Med. 185. Jahrgang, Nr.11, Juni 1997, S.2015–23, PMID 9166430, PMC 2196334 (freier Volltext).
